+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oral Herpes Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • PDF Icon

    Report

  • 70 Pages
  • November 2021
  • Region: Global
  • VPA Research
  • ID: 5464133
Oral Herpes pipeline drugs and companies, 2021- Phase, Mechanism of Action, Route, Licensing/collaboration, pre-clinical and clinical trials

The global comprehensive report on “Oral Herpes pipeline drugs and companies” presents key-decision makers with critical insights into Oral Herpes pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.

Oral Herpes pipeline Drug Snapshot, 2021


The Oral Herpes pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Oral Herpes. In addition to recent status, overview of drugs is included in the study. Wide range of Oral Herpes drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.

Oral Herpes drug development pipeline by phase


The Oral Herpes pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Oral Herpes pipeline candidates is provided in the report enables you to understand timetable developments in Oral Herpes therapeutic area.

Oral Herpes pipeline drug Technology, Licensing and Collaboration Details


Details of technologies used for development of Oral Herpes pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Oral Herpes research study. Companies looking to partner with other players are also detailed in the report.

Oral Herpes- mechanism of action of pipeline candidates


Oral Herpes pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Oral Herpes companies are identified to support decision makers target the most potential drugs under development.

Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Oral Herpes drug administration.

Oral Herpes Drugs- Preclinical and Clinical Trials


This chapter in Oral Herpes preclinical and clinical trials assists in gaining clear understanding of the timetable developments in Oral Herpes product area. Preclinical and clinical trial details of pipeline candidates for Oral Herpes are detailed in the report. Details including participants, duration, companies, locations and others are provided for the trials.

Oral Herpes companies and Profiles


Companies developing Oral Herpes pipeline products are analyzed in the industry report, presenting details of business overview, location, and year of establishment, contacts, key employees, and a brief business profile.

Oral Herpes Market Developments


The report presents the recent news and developments in the Oral Herpes pipeline industry. Progress of candidates, mergers, acquisitions, asset transactions, licensing, collaborations, partnership and joint ventures, regulatory approvals, marketing and other relevant news and deals are discussed in the report.

Reasons to Buy

  • Make better-informed decisions based on the current status of each of the pipeline drug candidate
  • Identify new business opportunities by evaluating the progress of the Oral Herpes R&D pipeline
  • Analyze the market and research segments based on a comprehensive analysis of Oral Herpes pipeline drugs and clinical trials
  • Identify Oral Herpes drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
  • Gain clear understanding of the Oral Herpes drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
  • Check the Oral Herpes pipeline progress of target companies and key strategies of leading players
  • Gain real-time insights into the global Oral Herpes pipeline news, developments and insights

Scope of the Report

  • Disease overview including Oral Herpes symptoms, widely used treatment options, companies and other details are included
  • Oral Herpes Pipeline Summary including the dominant phase type, number of drug candidates progressing to advanced phases, early stage pipeline candidates, leading companies, dominant route of mechanism and route of administration and other details are provided.
  • Oral Herpes pipeline drug count by phase, company and mechanism of action
  • Oral Herpes companies investing R&D resources in pipeline
  • Dominant Mechanism of Action
  • Most researched route of administration
  • For each pipeline candidate, drug, originator, co-developers, other companies, special status, phase, synonym, current status and other details are included
  • Clinical trial information for each Oral Herpes pipeline candidate are provided including preclinical, phase 1, phase 2 and phase 3 details
  • Oral Herpes companies including their business snapshot, business description and Oral Herpes pipelines are included.
  • Recent Oral Herpes market developments, pipeline news and deals are provided

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Oral Herpes Disease overview
2.2 Companies investing in Oral Herpes industry
3 Oral Herpes Pipeline Snapshot, 2021
3.1 Oral Herpes Pipeline Drugs- Dominant phase type
3.2 Oral Herpes pipeline Drugs- Leading Mechanism of Action
3.3 Oral Herpes Pipeline Drugs- Widely researched Route of Administration
3.4 Oral Herpes Pipeline- New Molecular Entity
3.5 Oral Herpes pipeline- Companies, Universities and Institutes
4. Oral Herpes Drug Profiles
4.1 Current Status of Oral Herpes Drug Candidates, 2021
4.2 Oral Herpes Drugs in Development- Originator/Licensor
4.3 Oral Herpes Drugs in Development- Route of Administration
4.4 Oral Herpes Drugs in Development- New Molecular Entity (NME)
5. Oral Herpes Clinical Trials
5.1 Preclinical Trial details
5.2 Phase 1 Clinical Trial Details
5.3 Phase 2 Clinical Trial Details
5.4 Phase 3 Clinical Trial Details
6. Oral Herpes Companies and Universities
6.1 Leading Oral Herpes companies researching in drug development
6.2 Leading Oral Herpes Universities/Institutes investing in drug development
7. Oral Herpes News and Deals
7.1 Recent Oral Herpes Market Developments
7.2 Pipeline Drug News Updates
7.3 Pipeline Company updates
8. Appendix
8.1 Sources and Research Methodology
8.2 Online Database
8.3 Primary and Secondary Methodology
8.4 Customization options
8.5 Contact